Battisti, Nicolò Matteo Luca
True, Victoria
Chaabouni, Narda
Chopra, Neha
Lee, Karla
Shepherd, Scott
Shapira-Rotenberg, Tal
Joshi, Rashi
McGrath, Sophie
Okines, Alicia
Parton, Marina
Turner, Nicholas
Mohammed, Kabir
Allen, Mark
Johnston, Stephen
Ring, Alistair https://orcid.org/0000-0003-1230-2973
Article History
Received: 6 September 2019
Accepted: 10 September 2019
First Online: 18 September 2019
Compliance with ethical standards
:
: Dr Battisti has received travel grants from Genomic Health and Pfizer and speaker fees from Pfizer. Dr Ring has received advisory board fees from Roche, Novartis, Pfizer, and Lilly; and speaker fees from Novartis and Pfizer. Prof Johnston has received consulting and advisory board fees from Eli Lilly, AstraZeneca, Puma Biotechnology Pfizer, and Novartis; and speaker fees from Pfizer, Novartis, and Eisai; and research funding from Pfizer and Puma Biotechnology. Prof Turner has received research funding from Merck Sharp & Dohme, Pfizer, AstraZeneca, Clovis, Roches, Tesaro, and Novartis. Dr Okines has received research funding from Pfizer and speaker fees from Roche. Dr McGrath has received travel grants from Genomic Health. Dr Parton, Dr Allen, Dr True, Dr Chaabouni, Dr Chopra, Dr Lee, Dr Shepherd, Dr Shapira-Rotenberg, Dr Joshi, and Mr Mohammed have no conflict of interest.
: This analysis was approved as a Service Evaluation by The Committee for Clinical Review of The Royal Marsden NHS Foundation Trust.
: No individual person’s data are included in the manuscript in any form and therefore no consents for publication were required.